Have a personal or library account? Click to login
SARS-CoV-2, SARS and MERS: Three formidable coronaviruses which have originated from bats Cover

SARS-CoV-2, SARS and MERS: Three formidable coronaviruses which have originated from bats

Open Access
|Feb 2021

References

  1. Ahmadpoor P., Rostaing L.: Why the immune system fails to mount an adaptive immune response to a COVID-19 infection. Transpl. Int., 2020; 33: 824–825
  2. Al-Tawfiq J.A., Zumla A., Memish Z.A.: Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med. Infect. Dis., 2014; 12: 422–428
  3. Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A., Cummings D.A., Alabdullatif Z.N., Assad M., Almulhim A., Makhdoom H., Madani H., Alhakeem R., Al-Tawfiq J.A., Cotton M., Watson S.J.: Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med., 2013; 369: 407–416
  4. Baud D., Qi X., Nielsen-Saines K., Musso D., Pomar L., Favre G.: Real estimates of mortality following COVID-19 infection. Lancet Infect. Dis., 2020; 20: 773
  5. Bosch B.J., van der Zee R., de Haan C.A., Rottier P.J.: The corona-virus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J. Virol., 2003; 77: 8801–8811
  6. Cai X.F., Chen J., Hu J.L., Long Q.X., Deng H.J., Liu P., Fan K., Liao P., Liu B.Z., Wu G.C., Chen Y.K., Li Z.J., Wang K., Zhang X.L., Tian W.G., et al.: A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of corona virus disease 2019. J. Infect. Dis., 2020; 222: 189–193
  7. Carter L.J., Garner L.V., Smoot J.W., Li Y., Zhou Q., Saveson C.J., Sasso J.M., Gregg A.C., Soares D.J., Beskid T.R., Jervey S.R., Liu C.: Assay techniques and test development for COVID-19 diagnosis. ACS Cent. Sci., 2020; 6: 591–605
  8. Cascella M., Rajnik M., Cuomo A., Dulebohn S.C., Di Napoli R.: Features, evaluation and treatment coronavirus (COVID-19). Stat-Pearls Publishing, 2020
  9. Chan J.F., Kok K.H., Zhu Z., Chu H., To K.K., Yuan S., Yuen K.Y.: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect., 2020; 9: 221–236
  10. Chen Z.M., Fu J.F., Shu Q., Chen Y.H., Hua C.Z., Li F.B., Lin R., Tang L.F., Wang T.L., Wang W., Wang Y.S., Xu W.Z., Yang Z.H., Ye S., Yuan T.M., Zhang C.M., Zhang Y.Y.: Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J. Pediatr., 2020: 16: 240–246
  11. de Wit E., van Doremalen N., Falzarano D., Munster V.J.: SARS and MERS: Recent insights into emerging coronaviruses. Nat. Rev. Microbiol., 2016;. 14: 523–534
  12. Donnelly C.A., Ghani A.C., Leung G.M., Hedley A.J., Fraser C, Riley S., Abu-Raddad L.J., Ho L.M., Thach T.Q., Chau P., Chan K.P., Lam T.H., Tse L.Y., Tsang T., Liu S.H., Kong J.H., Lau E.M., Ferguson N.M., Anderson R.M.: Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet, 2003; 361: 1761–1766
  13. Drosten C., Günther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguière A.M., Cinatl J., Eickmann M., Escriou N., et al.: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med., 2003; 348: 1967–1976
  14. Du Z., Xu X., Wu Y., Wang L., Cowling B.J., Meyers L.A.: Serial interval of COVID-19 among publicly reported confirmed cases. Emerg. Infect. Dis., 2020; 26: 1341–1343
  15. Fehr A.R., Perlman S.: Coronaviruses: an overview of their replication and pathogenesis. In: Coronaviruses. Methods and Protocols, eds.: H.J. Maier, E. Bickerton, P. Britton. Springer, 2015: 1–23
  16. Fields B.N., Knipe D.M., Howley P.M.: Fundamental Virology. Lippincott-Raven Philadelphia; 1996
  17. Gallagher T.M., Buchmeier M.J.: Coronavirus spike proteins in viral entry and pathogenesis. Virology, 2001; 279: 371–374
  18. García L.F.: Immune response, inflammation, and the clinical spectrum of COVID-19. Front. Immunol., 2020; 11: 1441
  19. Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., Penzar D., Perlman S., Poon L.L., Samborskiy D., Sidorov I.A., et al.: Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. BioRxiv, 2020. doi: https://doi.org/10.1101/2020.02.07.937862
  20. Gralinski L.E., Menachery V.D.: Return of the Coronavirus: 2019-nCoV. Viruses, 2020; 12: 135
  21. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L, Hui D.S., Du B., Li L.J., Zeng G., Yuen K.Y., Chen R.C., et al.: Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med., 2020; 382: 1708–1720
  22. Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W., Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W., Shortridge K.F., Yuen K.Y., Peiris J.S.M., Poon L.L.: Isolation and characterization of viruses related to the SARS corona-virus from animals in southern China. Science, 2003; 302: 276–278
  23. Haagmans B.L., Al Dhahiry S.H., Reusken C.B., Raj V.S., Galiano M., Myers R., Godeke G.J., Jonges M., Farag E., Diab A., Ghobashy H., Alhajri F., Al-Thani M., Al-Marri S.A., Al Romaihi H.E., et al.: Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation. Lancet Infect. Dis., 2014; 14: 140–145
  24. Habibzadeh P., Stoneman E.K.: The novel coronavirus: A bird’s eye view. Int. J. Occup. Environ. Med., 2020; 11: 65–71
  25. Han Q., Lin Q., Jin S., You L.: Recent insights into 2019-nCoV: A brief but comprehensive review. J. Infect., 2020; 80: 373–377
  26. Hijawi B., Abdallat M., Sayaydeh A., Alqasrawi S., Haddadin A., Jaarour N., Alsheikh S., Alsanouri T.: Novel coronavirus infections in Jordan, April 2012: Epidemiological findings from a retrospective investigation. East. Mediterr. Health J., 2013; 19: S12–S18
  27. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Müller M.A., Drosten C., Pöhlmann S.: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 2020; 181: 271–280
  28. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., et al.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395: 497–506
  29. Huang C., Wen T., Shi F.J., Zeng X.Y., Jiao Y.J.: Rapid detection of IgM antibodies against the SARS-CoV-2 virus via colloidal gold nanoparticle-based lateral-flow assay. ACS Omega, 2020; 5: 12550–12556
  30. Hunter J.C., Nguyen D., Aden B., Al Bandar Z., Al Dhaheri W., Abu Elkheir K., Khudair A., Al Mulla M., El Saleh F., Imambaccus H., Al Kaabi N., Sheikh F.A., Sasse J., Turner A., Abdel Wareth L., et al.: Transmission of Middle East respiratory syndrome corona-virus infections in healthcare settings, Abu Dhabi. Emerg. Infect. Dis., 2016; 22: 647–656
  31. Kanne J.P.: Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: Key points for the radiologist. Radiology, 2020; 295: 16–17
  32. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M., Ahuja A., Yung M.Y., Leung C.B., To K.F., Lui S.F., Szeto C.C., Chung S., Sung J.J.: A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med., 2003; 348: 1986–1994
  33. Lee P.I., Hsueh P.R.: Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J. Microbiol. Immunol. Infect., 2020; 53: 365–367
  34. Leo Y.S., Chen M., Heng B.H., Lee C.C.: Severe acute respiratory syndrome-Singapore, 2003. MMWR Morb. Mortal. Wkly. Rep., 2003; 52: 405–411
  35. Leung G.M., Hedley A.J., Ho L.M., Chau P., Wong I.O., Thach T.Q., Ghani A.C., Donnelly C.A., Fraser C., Riley S., Ferguson N.M., Anderson R.M., Tsang T., Leung P.Y., Wong V., Chan J.C., Tsui E., Lo S.V., Lam T.H.: The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients. Ann. Intern. Med., 2004; 141: 662–673
  36. Li P., Fu J.B., Li K.F., Liu J.N., Wang H.L., Liu L.J., Chen Y., Zhang Y.L., Liu S.L., Tang A., Tong Z.D., Yan J.B.: Transmission of COVID-19 in the terminal stages of the incubation period: A familial cluster. Int. J. Infect. Dis., 2020; 96: 452–453
  37. Liu Y., Gayle A.A., Wilder-Smith A., Rocklöv J.: The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med., 2020; 27: taaa021
  38. Lu C.W., Liu X.F., Jia Z.F.: 2019-nCoV transmission through the ocular surface must not be ignored. Lancet, 2020; 395: e39
  39. Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., et al.: Genomic characterisation and epidemiology of 2019 novel corona-virus: Implications for virus origins and receptor binding. Lancet, 2020; 395: 565–574
  40. Mirzaie A., Halaji M., Dehkordi F.S., Ranjbar R., Noorbazargan H.: A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement. Ther. Clin. Pract., 2020; 40: 101214
  41. Nishiura H., Kobayashi T., Yang Y., Hayashi K.., Miyama T., Kinoshita R., Linton N.M., Jung S.M., Yuan B., Suzuki A., Akhmetzhanov A.R.: The rate of underascertainment of novel coronavirus (2019-nCoV) infection: Estimation using Japanese passengers data on evacuation flights. J. Clin. Med., 2020; 9: 419
  42. Pasternak A.O., Spaan W.J., Snijder E.J.: Nidovirus transcription: How to make sense…? J. Gen. Virol., 2006; 87: 1403–1421
  43. Perlman S., Netland J.: Coronaviruses post-SARS: Update on replication and pathogenesis. Nat. Rev. Microbiol., 2009; 7: 439–450
  44. Phan T.: Novel coronavirus: From discovery to clinical diagnostics. Infect. Genet. Evol., 2020; 79: 104211
  45. Postnikova E.N., Pettitt J., Van Ryn C.J., Holbrook M.R., Bollinger L., Yú S., Caì Y., Liang J., Sneller M.C., Jahrling P.B., Hensley L.E., Kuhn J.H., Fallah M.P., Bennett R.S., Reilly C.: Scalable, semiautomated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples. PLoS One, 2019; 14: e0221407
  46. Poutanen S.M., Low D.E., Henry B., Finkelstein S., Rose D., Green K., Tellier R., Draker R., Adachi D., Ayers M., Chan A.K., Skowronski D.M., Salit I., Simor A.E., Slutsky A.S., et al: Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med., 2003; 348: 1995–2005
  47. Raj V.S., Farag E.A., Reusken C.B., Lamers M.M., Pas S.D., Voermans J., Smits S.L., Osterhaus A.D., Al-Mawlawi N., Al-Romaihi H.E., Al. Hajri M.M., El-Sayed A.M., Mohran K.A., Ghobashy H., Alhajri F., et al.: Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg. Infect. Dis., 2014; 20: 1339–1342
  48. Raj V.S., Mou H., Smits S.L., Dekkers D.H., Müller M.A., Dijkman R., Muth D., Demmers J.A., Zaki A., Fouchier R.A., Thiel V., Drosten C., Rottier P.J., Osterhaus A.D., Bosch B.J., et al.: Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature, 2013; 495: 251–254
  49. Reusken C.B., Haagmans B.L., Müller M.A., Gutierres C., Godeke G.J., Meyer B., Muth D., Raj V.S., Smits-De Vries L., Corman V.M., Drexler J.F., Smits S.L., El Tahir Y.E., De Sousa R., van Beek J., et al.: Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. Lancet Infect. Dis., 2013; 13: 859–866
  50. Shi Y., Wang Y., Shao C., Huang J., Gan J., Huang X., Bucci E., Piacentini M., Ippolito G., Melino G.: COVID-19 infection: The perspectives on immune responses. Cell Death Differ., 2020; 27: 1451–1454
  51. Tang Y.W., Schmitz J.E., Persing D.H., Stratton C.W.: Laboratory diagnosis of COVID-19: Current issues and challenges. J. Clin. Microbiol., 2020; 58: e00512–20
  52. Tindale L., Coombe M., Stockdale J.E., Garlock E.S., Lau W.Y., Saraswat M., Lee Y.H., Zhang L., Chen D., Wallinga J., Colijn C.: Transmission interval estimates suggest pre-symptomatic spread of COVID-19. MedRxiv, 2020: https://doi.org/10.1101/2020.03.03.20029983
  53. Tu W., Tang H., Chen F., Wei Y., Xu T., Liao K., Xiang N., Shi G., Li Q., Feng Z.: Epidemic update and risk assessment of 2019 novel coronavirus – China, January 28, 2020. China CDC Wkly., 2020; 2: 83–86
  54. Wan Y., Shang J., Graham R., Baric R.S., Li F.: Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J. Virol., 2020; 94: e00127–20
  55. Wandtke T., Woźniak J., Kopiński P.: Aptamers in diagnostics and treatment of viral infections. Viruses, 2015; 7: 751–780
  56. Wang J.T. Sheng W.H., Fang C.T., Chen Y.C., Wang J.L., Yu C.J., Chang S.C., Yang P.C.: Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg. Infect. Dis., 2004; 10: 818–824
  57. Wertheim J.O.: A glimpse into the origins of genetic diversity in the severe acute respiratory syndrome coronavirus 2. Clin. Infect. Dis., 2020; 71: 721–722
  58. Wise J.: Patient with new strain of coronavirus is treated in intensive care at London hospital. Br. Med. J., 2012; 345: e6455
  59. Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z.W., Tian J.H., Pei Y.Y., Yuan M.L., Zhang Y.L., Dai F.H., Liu Y., Wang O.M., et al.: A new coronavirus associated with human respiratory disease in China. Nature, 2020; 579: 265–269
  60. Wu J.L., Tseng W.P., Lin C.H., Lee T.F., Chung M.Y., Huang C.H., Chen S.Y., Hsueh P.R., Chen S.C.: Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2. J. Infect., 2020; 81: 435–442
  61. Xia S., Yan L., Xu W., Agrawal A.S., Algaissi A., Tseng C.T., Wang Q., Du L., Tan W., Wilson I.A., Jiang S., Yang B., Lu L.: A pan-corona-virus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci. Adv., 2019; 5: eaav4580
  62. Xu J., Zhao S., Teng T., Abdalla A.E., Zhu W., Xie L., Wang Y., Guo X.: Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses, 2020; 12: 244
  63. Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., Wang F.S.: Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med., 2020; 8: 420–422
  64. Zaigham M., Andersson O.: Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet. Gynecol. Scand., 2020: 99: 823–829
  65. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A.: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med., 2012; 367: 1814–1820
  66. Zhang F., Abudayyeh O.O., Gootenberg J.S.: A protocol for detection of COVID-19 using CRISPR diagnostics. https://www.broadinstitute.org/files/publications/special/COVID-19%20detection%20(updated).pdf
  67. Zhang H., Kang Z., Gong H., Xu D., Wang J., Li Z., Li Z., Cui X., Xiao J., Zhan J., Meng T., Zhou W., Liu J., Xu H.: Digestive system is a potential route of COVID-19 infection: An analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut, 2020; 69: 1010–1018
  68. Zhang W., Du R.H., Li B., Zheng X.S., Yang X.L., Hu B., Wang Y.Y., Xiao G.F., Yan B., Shi Z.L., Zhou P.: Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes. Emerg. Microbes Infect., 2020; 9: 386–389
  69. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., et al.: Discovery of a novel coronavirus associated with the recent pneumonia utbreak in humans and its potential bat origin. BioRxiv, 2020. https://doi.org/10.1101/2020.01.22.914952
  70. Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., Chen H.D., Chen J., Luo Y., Guo H., Jiang R.D., et al.: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020; 579: 270–273
Language: English
Page range: 91 - 100
Submitted on: Jul 3, 2020
Accepted on: Nov 20, 2020
Published on: Feb 17, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2021 Arezoo Mirzaei, Sharareh Moghim, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.